V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270020131 | 270009141 | 1.75 | null | Curative (C) | 2018-02-14 | 2018-02-22 | Rituximab | 2 | N | 270015108 | RITUXIMAB |
| 270020132 | 270009215 | 1.56 | 60 | null | 2016-05-05 | 2016-10-04 | Rituximab | 02 | N | 270015286 | RITUXIMAB |
| 270020133 | 270009319 | null | 43.1 | Curative (C) | 2018-12-28 | 2018-12-28 | LEAM | null | Y | 270015528 | LEAM |
| 270020134 | 270009404 | 1.73 | null | Curative (C) | 2016-09-08 | 2017-02-24 | ESHAP | null | N | 270015795 | ESHAP |
| 270020135 | 270016928 | 1.72 | 70 | Curative (C) | 2018-09-18 | 2018-09-30 | Rituximab | 02 | null | 270015884 | RITUXIMAB |
| 270020136 | 270009470 | 1.73 | 54 | Curative (C) | null | 2016-06-14 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 270015983 | RITUXIMAB |
| 270020137 | 270009540 | 1.91 | 88.2 | Adjuvant (A) | 2020-04-28 | 2020-04-28 | OEPA | null | null | 270016250 | OEPA |
| 270020138 | 270018409 | 1.7 | 17 | Curative (C) | 2015-12-15 | 2015-12-15 | ESHAP | 2 | N | 270016297 | ESHAP |
| 270020139 | 270014489 | 1.7 | 86.5 | Curative (C) | null | 2015-12-20 | ESHAP | 2 | N | 270016405 | ESHAP |
| 270020140 | 270009630 | null | null | Palliative (P) | 2015-06-30 | 2015-07-07 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016490 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270020141 | 270009651 | null | 62.9 | Neo-adjuvant (N) | 2019-04-04 | 2019-09-18 | Bevacizumab + Oxaliplatin +MdG | 2 | null | 270016559 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270020142 | 270009657 | 1.62 | 87.4 | Palliative (P) | 2018-04-13 | 2018-09-02 | HD EuroNet-PHL-C1 Relapsed ABVD | 02 | N | 270016596 | NOT MATCHED |
| 270020143 | 270018432 | 1.67 | 57.2 | Palliative (P) | 2018-12-17 | 2019-08-14 | CISPLATIN + FLUOROURACIL | N | N | 270016607 | CISPLATIN + FLUOROURACIL |
| 270020144 | 270009670 | 1.75 | null | null | 2019-01-30 | 2019-01-30 | CHLVPP | N | N | 270016619 | CHLVPP |
| 270020145 | 270014540 | 1.8 | 98.8 | Palliative (P) | 2016-09-02 | 2017-04-10 | Capecitabine (21 day) + Irinotecan | N | N | 270016660 | CAPECITABINE + IRINOTECAN |
| 270020146 | 270009725 | null | 77.8 | Curative (C) | 2014-06-14 | 2014-06-20 | CHOP R - 21 days | N | N | 270016761 | CHOP R |
| 270020147 | 270014572 | 1.71 | null | Palliative (P) | 2020-07-20 | 2020-07-28 | GEM-P | N | N | 270016828 | GEMCITABINE + PACLITAXEL |
| 270020148 | 270017048 | 1.65 | 91.5 | Palliative (P) | 2018-12-11 | 2018-12-26 | Oxaliplatin + Raltitrexed | 2 | N | 270016922 | VINBLASTINE |
| 270020149 | 270009808 | 1.87 | 69.8 | Curative (C) | 2019-10-15 | 2019-10-15 | GEMCITABINE | N | N | 270016989 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270020150 | 270009845 | 1.85 | 95.7 | Adjuvant (A) | 2017-03-31 | 2017-04-27 | IVE | N | N | 270017056 | IVE |
| 270020151 | 270009851 | 0 | 81.6 | Curative (C) | 2020-01-08 | 2020-01-11 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270017063 | GEMCITABINE |
| 270020152 | 270009906 | null | 107 | Curative (C) | 2016-06-12 | 2016-09-26 | ABVD R | N | N | 270017233 | OXALIPLATIN + RALTITREXED |
| 270020153 | 270009922 | 1.83 | 90.5 | Curative (C) | 2014-03-10 | 2014-03-26 | Cyclophosphamide High Dose | N | N | 270017260 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270020154 | 270014646 | 1.78 | null | Adjuvant (A) | 2018-01-30 | 2018-01-31 | Irinotecan | 2 | N | 270017290 | IRINOTECAN |
| 270020155 | 270018470 | 1.68 | 97.2 | Adjuvant (A) | 2018-12-11 | 2019-01-06 | Cisplatin 7 day | 02 | N | 270017330 | CARBOPLATIN |
| 270020156 | 270010010 | 1.66 | null | Palliative (P) | 2017-06-14 | 2017-06-14 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270017427 | BEAM + ALEMTUZUMAB |
| 270020158 | 270014733 | 1.59 | 79.8 | Curative (C) | 2014-12-21 | 2015-06-29 | ICE | 02 | N | 270018171 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270020159 | 270010170 | null | 51.6 | Not known (9) | 2016-01-07 | 2016-01-14 | ICE | 02 | null | 270018521 | GEMCITABINE + OXALIPLATIN |
| 270020160 | 270017148 | 1.76 | 83.36 | Curative (C) | 2014-05-11 | 2014-05-19 | Fludarabine + Melphalan RIC Allo | 2 | Y | 270018829 | VINCRISTINE |
| 270020161 | 270017167 | 1.77 | 0 | Curative (C) | 2019-11-01 | 2019-11-08 | ETOPOSIDE | 02 | N | 270019883 | CHOP |
| 270020162 | 270010544 | 1.73 | 49 | Curative (C) | 2018-03-27 | 2018-11-29 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | N | N | 270023166 | METHOTREXATE INTRATHECAL |
| 270020163 | 270010570 | 1.7 | 70 | Curative (C) | 2016-10-03 | 2016-10-13 | IMATINIB | null | null | 270023443 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270020164 | 270010736 | 1.66 | 86.2 | Curative (C) | 2018-11-19 | 2018-11-20 | Vinorelbine (oral) | N | null | 270025878 | SCOT TRIAL |
| 270020165 | 270010874 | 1.68 | 92.6 | Palliative (P) | 2020-01-28 | 2020-02-10 | ETOPOSIDE | N | N | 270021755 | ICE-R |
| 270020166 | 270017321 | 1.53 | null | null | 2018-05-21 | 2018-05-27 | Cisplatin + Docetaxel +Fluorouracil | N | null | 270023795 | FLUOROURACIL + RT |
| 270020167 | 270015084 | 1.63 | 57.5 | Palliative (P) | 2019-08-17 | 2019-08-26 | CISPLATIN + VINORELBINE | N | N | 270024838 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270020168 | 270006579 | null | null | null | 2017-12-14 | 2017-12-15 | ABVD | 2 | N | 270000967 | ABVD |
| 270020169 | 270006897 | 1.8 | 70.2 | Not known (9) | 2014-11-05 | 2015-02-10 | ABVD | 02 | N | 270003495 | ABVD |
| 270020170 | 270006966 | 1.7 | 55.8 | Curative (C) | 2019-01-04 | 2019-02-03 | Irinotecan + Modified De Gramont | null | N | 270003945 | IRINOTECAN + MDG |
| 270020171 | 270007079 | 1.82 | 94.3 | Adjuvant (A) | 2019-12-07 | 2019-12-07 | Oxaliplatin + Modified de Gramont | N | N | 270005026 | OXALIPLATIN + MDG |
| 270020172 | 270007110 | null | 78.5 | Curative (C) | 2019-08-20 | 2019-08-22 | Brentuximab | 2 | null | 270005418 | BRENTUXIMAB |
| 270020173 | 270007319 | 1.73 | 95.6 | Curative (C) | 2018-02-06 | 2018-02-13 | Capecitabine | N | N | 270007906 | CAPECITABINE |
| 270020174 | 270007413 | 1.7 | null | Curative (C) | 2020-01-17 | 2020-01-29 | Brentuximab | N | N | 270008766 | BRENTUXIMAB |
| 270020175 | 270019003 | 1.75 | 82.4 | Disease modification (D) | 2019-12-07 | 2020-01-19 | Brentuximab Vedotin | 02 | N | 270009154 | BRENTUXIMAB |
| 270020176 | 270007577 | 1.72 | 59.2 | Curative (C) | 2017-12-07 | 2017-12-14 | Capecitabine | N | N | 270009887 | CAPECITABINE |
| 270020177 | 270018081 | 1.9 | null | Palliative (P) | 2018-11-24 | 2019-03-09 | Capecitabine | N | N | 270010050 | CAPECITABINE |
| 270020178 | 270018105 | 0 | 37.7 | Curative (C) | 2016-05-20 | 2016-06-04 | Trial Unspecified | 02 | N | 270010476 | TRIAL |
| 270020179 | 270008134 | null | 47 | Curative (C) | 2018-04-11 | 2018-07-15 | Escalated BEACOPP | null | null | 270011914 | BEACOPP |
| 270020180 | 270008143 | 1.71 | 96 | Curative (C) | 2015-07-03 | 2015-09-01 | COPP + Dacarbazine | 02 | N | 270011935 | COPP + DACARBAZINE |
| 270020181 | 270019084 | 1.6 | 66.5 | Palliative (P) | 2014-05-21 | 2015-03-10 | Cetuximab 14 day | null | null | 270012187 | CETUXIMAB |